Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

What is Genetic Engineering?

What is Genetic Engineering?

Types of Receptors: Cell Surface Receptors

Types of Receptors: Cell Surface Receptors

Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...

Internal Receptors

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Nature medicine·2026

Same author

A reassessment of anti-CAR T-cell expansion strategies.

Blood·2026

Same author

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026

Same author

Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

Transplantation and cellular therapy·2026

Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.

Neuro-oncology advances·2026

Same journal

Minor histocompatibility antigen TCR-T.

Blood advances·2026

Same journal

Increased Gene Therapy Efficacy Through the Use of Extended Half-Life Clotting Factors.

Blood advances·2026

Same journal

Bone Mineral Density in Hemophilia and VWD.

Blood advances·2026

Same journal

Differential perforin sensitivity drives lineage-dependent resistance to CAR T-cell killing in blood cancer cell lines.

Blood advances·2026

Same journal

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.

Blood advances·2026

Same journal

Predictive Modeling of Clonal Hematopoiesis Across Diverse Cohorts.

Blood advances·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Developing T-cell therapies for lymphoma without receptor engineering.

Melanie Grant¹, Catherine M Bollard^1,2

¹Center for Cancer and Immunology Research, Children's National Health System, Washington, DC; and.

|January 4, 2018

Summary

This summary is machine-generated.

T-cell therapy offers new lymphoma treatments beyond engineered receptors. Ex vivo expanded antigen-specific T cells improve patient responses and survival, marking a significant advance in cancer immunotherapy.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Related Experiment Videos

Last Updated: Feb 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Area of Science:

Immunology
Oncology
Cellular Therapy

Background:

T-cell therapy is a promising approach for treating lymphoma.
Treatment efficacy depends on patient immune status and disease stage.
Existing T-cell therapies include engineered receptors and ex vivo expanded T cells.

Purpose of the Study:

To review T-cell therapeutics for lymphoma beyond receptor engineering.
To highlight alternative T-cell-based treatment strategies.

Main Methods:

Literature review of T-cell therapies for lymphoma.
Focus on ex vivo expansion of antigen-specific T cells.
Exclusion of chimeric antigen receptor and artificial T-cell receptor engineering.

Main Results:

Ex vivo expanded antigen-specific T cells show enhanced clinical responses.
These T-cell approaches improve overall survival in lymphoma patients.
Multiple T-cell therapeutic strategies exist beyond receptor modification.

Conclusions:

T-cell therapy, particularly ex vivo expansion, offers viable treatment options for lymphoma.
These methods represent significant progress in lymphoma treatment.
Further research into T-cell therapeutics beyond receptor engineering is warranted.